AIDA STEMI: no benefit for intracoronary abciximab

Lancet. 2012 Mar 10;379(9819):875-877. doi: 10.1016/S0140-6736(12)60079-8. Epub 2012 Feb 21.
No abstract available

Publication types

  • Comment

MeSH terms

  • Abciximab
  • Angioplasty, Balloon, Coronary*
  • Antibodies, Monoclonal / administration & dosage*
  • Female
  • Humans
  • Immunoglobulin Fab Fragments / administration & dosage*
  • Male
  • Myocardial Infarction / therapy*
  • Platelet Aggregation Inhibitors / administration & dosage*

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Abciximab